- Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference
- Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
- Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Key statistics
On Monday, Kezar Life Sciences Inc (KZR:NAQ) closed at 0.65, 2.88% above its 52-week low of 0.6318, set on Jun 21, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.635 |
---|---|
High | 0.66 |
Low | 0.635 |
Bid | 0.6377 |
Offer | 0.6595 |
Previous close | 0.6428 |
Average volume | 398.28k |
---|---|
Shares outstanding | 72.80m |
Free float | 62.00m |
P/E (TTM) | -- |
Market cap | 46.80m USD |
EPS (TTM) | -1.40 USD |
Data delayed at least 15 minutes, as of Jun 24 2024 21:00 BST.
More ▼